MaaT Pharma to Host Virtual KOL Event on MaaT013 and MaaT033 Following ASH 2023 Presentations…
MaaT PharmaDecember 12, 2023
MaaT Pharma Presents Positive Results with Lead Product MaaT013 and Provides Insights on Ongoing Phase…
MaaT PharmaDecember 11, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaDecember 5, 2023
MaaT Pharma, Leader in Development of Microbiome-Based Therapies in Oncology, Awarded Government Funding for Clinical…
MaaT PharmaNovember 30, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaNovember 13, 2023
MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results Independent Data Safety…
MaaT PharmaNovember 9, 2023